|
HY-101381-10mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-100mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-25mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-5mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-50mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101576-10mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-100mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-25mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-5mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-50mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101605-1mg
|
MedChemexpress LLC
|
Prodipine hydrochloride [CAS 31314-39-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101627-1mg
|
MedChemexpress LLC
|
YM17E [CAS 124900-72-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101664-10mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-100mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-2mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-5mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-50mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-102001-10mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-102001-25mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-102001-5mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-102001-50mg
|
MedChemexpress LLC
|
Tomaymycin DM [CAS 945490-09-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103157-10mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103157-100mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103157-5mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103157-50mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
